Thimmesch Michael J, Kurkowski Sarah C, Keller Jonas, Kuechly Henry A, Le Sophia, Kloby Michael, Branam Barton, Utz Christopher, Grawe Brian
Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Department of Orthopaedic Surgery, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Orthop J Sports Med. 2025 Jun 24;13(6):23259671251339170. doi: 10.1177/23259671251339170. eCollection 2025 Jun.
Overall outcomes of revision anterior cruciate ligament reconstruction (ACLR) are well documented, although the durability of results, to the best of the authors' knowledge, has not been compared between short-term and midterm follow-up.
The primary aim was to assess the durability of revision ACLR outcomes at <5 years after revision (short-term) to outcomes at ≥5 years after revision (midterm). For this study's purposes, durability was defined as not requiring additional revision surgery or the maintenance of good patient-reported outcomes (PROs). The secondary aims were to compare the outcomes between male and female patients, between patients with allografts and those with autografts, and between patients with traumatic mechanisms of a rerupture and those with atraumatic mechanisms of a rerupture.
Cohort study; Level of evidence, 3.
This was a retrospective chart review with the prospective collection of PROs in 53 knees that underwent revision ACLR. PROs included scores for the International Knee Documentation Committee subjective knee form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Marx activity rating scale, ACL-Return to Sport after Injury scale, visual analog scale for pain, and satisfaction. The time to return to sport or activity and the incidence of reruptures were collected as well. Data were analyzed via the Mann-Whitney test, chi-square test, Fisher exact test, and odds ratios.
The mean follow-up from first revision surgery was 5.29 ± 2.96 years (range, 2.0-20.5 years) for the entire cohort. No significant differences in outcomes were found between the short-term (<5 years from revision; 21/53 knees) and midterm (≥5 years from revision; 32/53 knees) groups, except in satisfaction (4.0/5 vs 2.5/5, respectively; = .014) and requiring second revision surgery (0.0% vs 25.0%, respectively; = .016). The mechanism of a rupture after primary ACLR leading to revision ACLR was traumatic in 64.7% and atraumatic in 35.3%, but no difference in outcomes was found based on the mechanism of reinjuries ( > .05). When comparing male to female patients, male patients were more active based on the Marx score at the time of follow-up than female patients (7.0 vs 2.0, respectively; = .046). Patients treated with autografts were younger and had higher KOOS Activities of Daily Living subscores than those treated with allografts, although no other differences were found ( > .05).
Our study demonstrates that revision ACLR offered patients durable results after the failure of primary ACLR from short-term to midterm follow-up. Patient sex and graft choice did not drastically affect postoperative outcomes. Orthopaedic surgeons may decide, based on their clinical acumen, which graft choice is best for the individual patient and be confident that revision ACLR can achieve desirable results for patients, regardless of the reinjury mechanism and sex. Future work on this topic is needed to look at long-term results.
翻修前交叉韧带重建术(ACLR)的总体结果已有充分记录,不过据作者所知,短期和中期随访结果的持久性尚未进行比较。
主要目的是评估翻修术后<5年(短期)的翻修ACLR结果的持久性与翻修术后≥5年(中期)的结果的持久性。本研究中,持久性定义为不需要额外的翻修手术或维持良好的患者报告结局(PROs)。次要目的是比较男性和女性患者之间、同种异体移植物患者和自体移植物患者之间、再次断裂有创伤机制的患者和再次断裂无创伤机制的患者之间的结局。
队列研究;证据等级,3级。
这是一项回顾性病历审查,前瞻性收集了53例接受翻修ACLR的膝关节的PROs。PROs包括国际膝关节文献委员会主观膝关节表格评分、膝关节损伤和骨关节炎结局评分(KOOS)、马克思活动评分量表、ACL损伤后恢复运动量表、疼痛视觉模拟量表和满意度。还收集了恢复运动或活动的时间以及再次断裂的发生率。通过曼-惠特尼检验、卡方检验、费舍尔精确检验和比值比分析数据。
整个队列首次翻修手术后的平均随访时间为5.29±2.96年(范围,2.0 - 20.5年)。短期(翻修后<5年;21/53膝)和中期(翻修后≥5年;32/53膝)组之间在结局方面未发现显著差异,除了满意度(分别为4.0/5和2.5/5;P = 0.014)和需要二次翻修手术(分别为0.0%和25.0%;P = 0.016)。初次ACLR导致翻修ACLR的初次断裂机制为创伤性的占64.7%,无创伤性的占35.3%,但基于再次损伤机制在结局方面未发现差异(P>0.05)。比较男性和女性患者时,随访时基于马克思评分男性患者比女性患者更活跃(分别为7.0和2.0;P = 0.046)。接受自体移植物治疗的患者比接受同种异体移植物治疗的患者更年轻,且KOOS日常生活活动子评分更高,不过未发现其他差异(P>0.05)。
我们的研究表明,从短期到中期随访,翻修ACLR在初次ACLR失败后为患者提供了持久的结果。患者性别和移植物选择并未对术后结局产生重大影响。骨科医生可以根据他们的临床判断,决定哪种移植物选择最适合个体患者,并确信翻修ACLR无论再次损伤机制和性别如何都能为患者取得理想的结果。关于这个主题未来需要研究长期结果。